eyeforpharma
Digital/ Views & Analysis/ Views and analysis
Why Norgine is embracing AI chatbots for medical information
George Underwood
AI, chatbots, eyeforpharma, Norgine
0 Comment
Equal coronavirus vaccine access a “real issue”
George Underwood
coronavirus vaccine, COVID-19, eyeforpharma, vaccines
0 Comment
COVID-19 the time for digital health companies to “prove their worth”
George Underwood
coronavirus, COVID-19, eyeforpharma
0 Comment
COVID-19 could cause ‘digital reset’ for pharma
George Underwood
coronavirus, COVID-19, eyeforpharma
0 Comment
Pharma companies that don’t change during COVID-19 will be ‘new Kodaks of this world’
George Underwood
coronavirus, COVID-19, eyeforpharma
0 Comment
Patients/ Views & Analysis/ Views and analysis
The many faces of patient-pharma co-creation
George Underwood
eyeforpharma, Merck KGaA, patient centricity, patient engagement
0 Comment
Patients/ Views & Analysis/ Views and analysis
eyeforpharma Patient Summit Europe roundup
mike.hammerton@pharmaphorum.com
eyeforpharma, Patient Summit
0 Comment
Digital/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Real world evidence, digital partnerships and the future of pharma
George Underwood
AstraZeneca, eyeforpharma, Real World Evidence, RWE
0 Comment